Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20748-53. doi: 10.1073/pnas.1113801108. Epub 2011 Dec 5.
Seasonal epidemics caused by influenza virus are driven by antigenic changes (drift) in viral surface glycoproteins that allow evasion from preexisting humoral immunity. Antigenic drift is a feature of not only the hemagglutinin (HA), but also of neuraminidase (NA). We have evaluated the antigenic evolution of each protein in H1N1 and H3N2 viruses used in vaccine formulations during the last 15 y by analysis of HA and NA inhibition titers and antigenic cartography. As previously shown for HA, genetic changes in NA did not always lead to an antigenic change. The noncontinuous pattern of NA drift did not correspond closely with HA drift in either subtype. Although NA drift was demonstrated using ferret sera, we show that these changes also impact recognition by NA-inhibiting antibodies in human sera. Remarkably, a single point mutation in the NA of A/Brisbane/59/2007 was primarily responsible for the lack of inhibition by polyclonal antibodies specific for earlier strains. These data underscore the importance of NA inhibition testing to define antigenic drift when there are sequence changes in NA.
季节性流感疫情是由流感病毒表面糖蛋白的抗原性变化(漂移)引起的,这种变化使病毒能够逃避预先存在的体液免疫。抗原漂移不仅是血凝素(HA)的特征,也是神经氨酸酶(NA)的特征。我们通过分析血凝抑制和抗原图谱,评估了过去 15 年中用于疫苗配方的 H1N1 和 H3N2 病毒中每种蛋白的抗原进化。与之前的 HA 研究结果一致,NA 中的遗传变化并不总是导致抗原变化。两种亚型的 NA 漂移都没有与 HA 漂移密切对应。尽管使用雪貂血清证明了 NA 漂移,但我们表明这些变化也会影响人血清中 NA 抑制抗体的识别。值得注意的是,A/Brisbane/59/2007 株 NA 中的单点突变主要导致针对早期株的多克隆抗体无法抑制。这些数据强调了在 NA 发生序列变化时,进行 NA 抑制检测以确定抗原漂移的重要性。